Sites NOW

Evolving Best Practices for Site Success.

Casey Orvin

Casey Orvin

SVP of Pharmaceutical Relationships
Irvine California
Timezone: America/New_York

Casey Orvin currently serves as Senior VP of Pharmaceutical Relationships for StudyKIK, a full- service patient recruitment and retention technology company, and also as Honorary President of the Society for Clinical Research Sites (SCRS), a global organization representing nearly 10,000 clinical research sites in 47 countries within the pharmaceutical industry. Orvin began his career leading a large pharmaceutical research site network, Research Solutions. In 2007, he was recruited to join Clinical Research Advantage/Radiant as Executive Vice President of Business Development and successfully led a network of over 75 research sites conducting clinical trials for pharmaceuticals, vaccines, and medical devices. Under Orvin’s leadership, several crucial partnerships were formed with major pharmaceutical companies which fueled the company’s rapid growth both geographically and within the medical community. Orvin facilitated the acquisition of two competitors securing the company’s spot as the largest clinical research site network in the US. In 2015, Orvin and the executive team at Radiant merged with the largest site network in the world, Synexus. Under Orvin’s leadership, Synexus continued to expand to 215 global clinical sites in 4 continents and over 15 countries. Orvin is passionate about representing the site voice within the industry while ensuring every research patient’s journey is a positive one.
As a thought-leader in the industry, Orvin is regularly sought after as a keynote speaker and panelist and is often quoted by the leading publications covering the clinical research landscape. In 2020, Orvin was recognized in PharmaVoice as one of the 100 Most Inspiring People in the industry.


Date & Time (EST) Title Role
Tuesday, April 13, 2021
11:30am - 1:00pm
Patient Engagement: What Matters Most Presenter


Send a Message

Send an email message to Casey Orvin: